(Q55033164)

16 June 2018

title

Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. (English)

1 reference

16 June 2018

main subject

chronic fatigue syndrome

1 reference

5

1 reference

16 June 2018

author name string

Scott LV

1

1 reference

16 June 2018

Salahuddin F

2

1 reference

16 June 2018

Cooney J

3

1 reference

16 June 2018

Svec F

4

1 reference

16 June 2018

publication date

1 July 1999

1 reference

16 June 2018

Journal of Affective Disorders

published in

1 reference

16 June 2018

volume

54

1 reference

16 June 2018

issue

1-2

1 reference

16 June 2018

page(s)

129-137

1 reference

16 June 2018

Changes in growth hormone, insulin, insulinlike growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Dehydroepiandrosterone: antiglucocorticoid action in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Contrasting neuroendocrine responses in depression and chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Dissociation of Cortisol and Adrenal Androgen Secretion in Patients with Secondary Adrenal Insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Neuroendocrine correlates of chronic fatigue syndrome: a brief review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Psychological, behavioral and biochemical risk factors for coronary artery disease among American and Italian male corporate managers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

A PRELIMINARY INVESTIGATION OF STEROID EXCRETION IN DEPRESSED PATIENTS BEFORE AND AFTER ELECTROL-CONVULSIVE THERAPY

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Plasma cortisol in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Chronic fatigue syndrome: a working case definition.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

ACTH, cortisol, and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Effect of insulin on serum levels of dehydroepiandrosterone metabolites in men

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Evidence for adrenocortical adaptation to severe illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Enhancement of hippocampal acetylcholine release by the neurosteroid dehydroepiandrosterone sulfate: an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Dehydroisoandrosterone is secreted episodically and synchronously with cortisol by normal man.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

The low dose ACTH test in chronic fatigue syndrome and in health

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

24 Hour Urinary Dehydroepiandosterone Sulfate in Unipolar Depression Treated with Cognitive and/or Pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Role of ACTH in the secretion of free dehydroepiandrosterone and its sulfate ester in man

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Relationship of body fat percentage and fat distribution with dehydroepiandrosterone sulfate in premenopausal females.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Dehydroepiandrosterone (DHEA) treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

Serum dehydroepiandrosterone sulfate concentrations in secondary adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900169-4

7 January 2021

10.1016/S0165-0327(98)00169-4

Identifiers

DOI

1 reference

16 June 2018

1 reference

16 June 2018